Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Q: What does CUSIP 30050B101 represent in this 13F holders report?

CUSIP 30050B101 is the security identifier for EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in Q1 2018?

145 institutional investors reported EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share for Q1 2018. Use the holders table for investor-level position and value details.

CUSIP: 30050B101

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding: 112,318,617
Total 13F shares: 79,341,302
Share change: +3,442,398
Total reported value: $1,130,145,805
Put/Call ratio: 103%
Price per share: $14.25
Number of holders: 145
Value change: +$51,206,773
Number of buys: 74
Number of sells: 64

Quarterly Holders Quick Answers

What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 30050B101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	7%	7,889,000	$97,035,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	6.7%	7,470,074	$91,882,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	4.5%	5,015,533	$61,691,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	3.3%	3,762,203	$46,274,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	3.1%	3,439,621	$42,307,000	—	31 Dec 2017	13F
BLAIR WILLIAM & CO/IL	13F	Company	2.6%	2,968,244	$36,509,000	—	31 Dec 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.5%	2,816,786	$34,646,000	—	31 Dec 2017	13F
RIVERBRIDGE PARTNERS LLC	13F	Company	2.4%	2,675,753	$32,912,000	—	31 Dec 2017	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	2%	2,267,357	$27,888,000	—	31 Dec 2017	13F
FORMULA GROWTH LTD	13F	Company	1.8%	2,043,700	$25,138,000	—	31 Dec 2017	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	1.8%	2,029,190	$25,056,000	—	31 Dec 2017	13F
Elk Creek Partners, LLC	13F	Company	1.8%	1,981,080	$24,367,000	—	31 Dec 2017	13F
FMR LLC	13F	Company	1.7%	1,877,875	$23,098,000	—	31 Dec 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.6%	1,786,361	$21,972,000	—	31 Dec 2017	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	1.4%	1,607,880	$19,777,000	—	31 Dec 2017	13F
TimesSquare Capital Management, LLC	13F	Company	1.4%	1,584,950	$19,495,000	—	31 Dec 2017	13F
THORNBURG INVESTMENT MANAGEMENT INC	13F	Company	1.4%	1,546,816	$19,026,000	—	31 Dec 2017	13F
Granahan Investment Management, LLC	13F	Company	1.3%	1,504,196	$18,502,000	—	31 Dec 2017	13F
CITADEL ADVISORS LLC	13F	Company	1%	1,175,780	$14,462,000	—	31 Dec 2017	13F
WADDELL & REED FINANCIAL INC	13F	Company	1%	1,173,387	$14,433,000	—	31 Dec 2017	13F
MACKENZIE FINANCIAL CORP	13F	Company	1%	1,146,242	$14,099,000	—	31 Dec 2017	13F
Aberdeen Group plc	13F	Company	0.97%	1,085,568	$13,380,000	—	31 Dec 2017	13F
Casdin Capital, LLC	13F	Company	0.96%	1,077,500	$13,253,000	—	31 Dec 2017	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.96%	1,076,377	$13,239,000	—	31 Dec 2017	13F
KORNITZER CAPITAL MANAGEMENT INC /KS	13F	Company	0.9%	1,006,365	$12,378,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	0.86%	967,025	$11,892,000	—	31 Dec 2017	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.84%	945,560	$11,630,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.73%	817,257	$10,053,000	—	31 Dec 2017	13F
EDMOND DE ROTHSCHILD HOLDING S.A.	13F	Company	0.68%	760,000	$9,348,000	—	31 Dec 2017	13F
GABELLI FUNDS LLC	13F	Company	0.67%	753,000	$9,262,000	—	31 Dec 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.67%	751,900	$9,248,370	—	31 Dec 2017	13F
Point72 Asset Management, L.P.	13F	Company	0.6%	671,300	$8,257,000	—	31 Dec 2017	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.55%	620,040	$7,626,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.45%	503,415	$6,192,000	—	31 Dec 2017	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.44%	491,982	$6,051,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.4%	447,181	$5,498,000	—	31 Dec 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.39%	441,519	$5,431,000	—	31 Dec 2017	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.37%	420,000	$5,166,000	—	31 Dec 2017	13F
Cortina Asset Management, LLC	13F	Company	0.37%	413,406	$5,085,000	—	31 Dec 2017	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.36%	400,000	$4,920,000	—	31 Dec 2017	13F
Lombard Odier Asset Management (USA) Corp	13F	Company	0.34%	379,441	$4,667,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.32%	358,186	$4,406,000	—	31 Dec 2017	13F
Invesco Ltd.	13F	Company	0.31%	351,132	$4,319,000	—	31 Dec 2017	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.27%	298,850	$3,676,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.26%	297,455	$3,659,000	—	31 Dec 2017	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.2%	219,520	$2,808,000	—	31 Dec 2017	13F
MACQUARIE GROUP LTD	13F	Company	0.16%	176,012	$2,165,000	—	31 Dec 2017	13F
GAMCO INVESTORS, INC. ET AL	13F	Company	0.15%	166,003	$2,042,000	—	31 Dec 2017	13F
White Pine Investment CO	13F	Company	0.15%	165,140	$2,031,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.14%	154,430	$1,900,000	—	31 Dec 2017	13F

Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q1 2018

As of 31 Mar 2018, Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,341,302 shares. The largest 10 holders included Capital Research Global Investors, JPMORGAN CHASE & CO, Bank of New York Mellon Corp, VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, RIVERBRIDGE PARTNERS LLC, BLAIR WILLIAM & CO/IL, Elk Creek Partners, LLC, and FORMULA GROWTH LTD. This page lists 145 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

151

Q1 2018 holders

145

Holder diff

-6

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.